These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 1977728

  • 21. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [Abstract] [Full Text] [Related]

  • 22. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T.
    Prog Clin Biol Res; 1986 Jun; 223():203-16. PubMed ID: 3468516
    [Abstract] [Full Text] [Related]

  • 23. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
    Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K, Inoko K, Wakusawa S, Kajita S, Hasegawa T, Takagi K, Koyama M.
    Cancer Res; 1993 Apr 01; 53(7):1555-9. PubMed ID: 8095855
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and structure--activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance.
    Tasaka S, Ohmori H, Gomi N, Iino M, Machida T, Kiue A, Naito S, Kuwano M.
    Bioorg Med Chem Lett; 2001 Jan 22; 11(2):275-7. PubMed ID: 11206476
    [Abstract] [Full Text] [Related]

  • 26. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E, Matsushita R, Negishi H, Nomura M, Harada S, Yamamoto H, Miyamoto K, Ichimura F.
    J Pharm Sci; 1995 Oct 22; 84(10):1205-9. PubMed ID: 8801335
    [Abstract] [Full Text] [Related]

  • 27. Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein.
    Fleming GF, Amato JM, Agresti M, Safa AR.
    Cancer Chemother Pharmacol; 1992 Oct 22; 29(6):445-9. PubMed ID: 1348973
    [Abstract] [Full Text] [Related]

  • 28. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
    Loor F, Boesch D, Gavériaux C, Jachez B, Pourtier-Manzanedo A, Emmer G.
    Br J Cancer; 1992 Jan 22; 65(1):11-8. PubMed ID: 1346365
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells.
    Ido M, Nagao Y, Higashigawa M, Shibata T, Taniguchi K, Hamazaki M, Sakurai M.
    Br J Cancer; 1991 Dec 22; 64(6):1103-7. PubMed ID: 1684908
    [Abstract] [Full Text] [Related]

  • 31. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D, Schmidt H.
    Biochem Pharmacol; 1986 Feb 15; 35(4):673-8. PubMed ID: 3947398
    [Abstract] [Full Text] [Related]

  • 32. Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models.
    Watanabe T, Naito M, Oh-hara T, Itoh Y, Cohen D, Tsuruo T.
    Jpn J Cancer Res; 1996 Feb 15; 87(2):184-93. PubMed ID: 8609068
    [Abstract] [Full Text] [Related]

  • 33. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 34. In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.
    Cros S, Guilbaud N, Berlion M, Dunn T, Regnier G, Dhainaut A, Atassi G, Bizzari JP.
    Cancer Chemother Pharmacol; 1992 Nov 03; 30(6):491-4. PubMed ID: 1394807
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T, Nakagawa M, Shiraishi N, Yoshida T, Kiyosue T, Arita M, Akiyama S, Kuwano M.
    J Natl Cancer Inst; 1986 May 03; 76(5):947-53. PubMed ID: 3457980
    [Abstract] [Full Text] [Related]

  • 37. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.
    Tsuruo T, Matsuzaki T, Matsushita M, Saito H, Yokokura T.
    Cancer Chemother Pharmacol; 1988 May 03; 21(1):71-4. PubMed ID: 3342468
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
    Kato T, Suzumura Y.
    J Natl Cancer Inst; 1987 Sep 03; 79(3):527-32. PubMed ID: 3476792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.